Skip to main content
Clinical Trials/JPRN-jRCT1062210068
JPRN-jRCT1062210068
Completed
Phase 1

Safety verification of robot-assisted laparoscopic resection for transverse colon cancer

Ogi Yusuke0 sites4 target enrollmentJanuary 9, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Transverse colon cancer
Sponsor
Ogi Yusuke
Enrollment
4
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Four cases were reviewed in the present study, and the surgical procedures were two extended right hemicolectomy, one left hemicolectomy, and one transverse colon resection, with no open conversion. The median operative time was 422 minutes (245-552), median blood loss was 0 ml (0-50), and there were no postoperative complications. Median postoperative hospital stay was 6 (6-7) days. The operation was performed without any apparent complications.

Registry
who.int
Start Date
January 9, 2022
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ogi Yusuke

Eligibility Criteria

Inclusion Criteria

  • Patients with transverse colon cancer scheduled for surgery

Exclusion Criteria

  • Patients with severe abdominal aortic aneurysms

Outcomes

Primary Outcomes

Not specified

Similar Trials